DEVELOPMENT OF A HUMANIZED DISULFIDE-STABILIZED ANTI-BETA-P185(HER2) FV-BETA-LACTAMASE FUSION PROTEIN FOR ACTIVATION OF A CEPHALOSPORIN DOXORUBICIN PRODRUG Article

RODRIGUES, ML, PRESTA, LG, KOTTS, CE et al. (1995). DEVELOPMENT OF A HUMANIZED DISULFIDE-STABILIZED ANTI-BETA-P185(HER2) FV-BETA-LACTAMASE FUSION PROTEIN FOR ACTIVATION OF A CEPHALOSPORIN DOXORUBICIN PRODRUG . CANCER RESEARCH, 55(1), 63-70.

cited authors

  • RODRIGUES, ML; PRESTA, LG; KOTTS, CE; WIRTH, C; MORDENTI, J; OSAKA, G; WONG, WLT; NUIJENS, A; BLACKBURN, B; CARTER, P

sustainable development goals

authors

publication date

  • January 1, 1995

published in

keywords

  • ANTI-P185HER2 ANTIBODY
  • BISPECIFIC ANTIBODIES
  • CONSTRUCTION
  • ESCHERICHIA-COLI
  • EXPRESSION
  • HER2 PROTOONCOGENE
  • HUMAN CANCER
  • HUMAN-BREAST
  • Life Sciences & Biomedicine
  • MONOCLONAL-ANTIBODY
  • Oncology
  • Science & Technology
  • TUMOR-CELL LINES

publisher

  • AMER ASSOC CANCER RESEARCH

start page

  • 63

end page

  • 70

volume

  • 55

issue

  • 1